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Abstract
Background: Different species of apicomplexan protozoans of the genera Hepatozoon and Cytauxzoon can infect
domestic cats, but their epidemiology and clinical relevance are not fully understood. The aim of this study was to
assess the molecular prevalence of Hepatozoon spp. and Cytauxzoon spp. and to identify associated risk factors and
clinical and laboratory abnormalities in a population of cats from Madrid, Spain.
Methods: Six hundred and forty-four client-owned and stray cats from Madrid, Spain, were included in this study.
DNA samples were analyzed by two polymerase chain reaction (PCR) tests to detect a partial sequence of the 18S
rRNA gene of Hepatozoon spp. and Cytauxzoon spp. In order to evaluate possible associations between infection by
these protozoans and epidemiological or clinical parameters, data were collected related to: the season of sample
collection, age, gender, spayed/neutered status, breed, living area, lifestyle, outdoor access, contact with other
animals, prey on wild animals, history of tick or flea infestation, travel history, ectoparasiticide treatment, previous
blood transfusion, previous tetracycline administration in the last 60 days, Feline Leukemia virus (FeLV) and Feline
Immunodeficiency virus (FIV) status, positivity to other vector-borne diseases, the presence or absence of clinical
signs and hematological or biochemical alterations.
Results: DNA of Hepatozoon spp. and Cytauxzoon sp. was amplified from the blood of 10 (1.6%) and 8 (1.2%) cats,
respectively. Previous treatment with tetracyclines in the last 60 days, previous administration of blood transfusion, a
decrease in haematocrit and an increase in creatinine were associated with Hepatozoon spp. infection. Cytauxzoon
sp. infection was more frequent in samples collected during the winter months and in cats living in rural areas. This
infection was associated with a FIV-positive status. Some of the cats that were positive for Hepatozoon spp. or
Cytauxzoon sp. had been exposed to other vector-borne pathogens, such as Ehrlichia canis and Bartonella henselae.
Conclusions: Our results indicate that cats from Madrid, central Spain, are infected with Hepatozoon spp. and
Cytauxzoon sp., although with a low prevalence. Further studies are needed to determine the virulence of these
agents in Spanish cats.
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Background
Feline vector-borne diseases are considered emerging or
re-emerging diseases. Their epidemiology is changing,
showing a wider geographical distribution and increasing
global prevalence, due to climate changes and
environmental, demographic and human behavioural
factors [1–3]. All these factors favour contact between
wildlife reservoir hosts and invertebrate vectors with
humans and pets. Although several vector-borne
agents cause disease and even death in the domestic
cat, the detection of others can be challenging be-
cause of their occurrence in healthy cats, the presence
of unspecific clinical signs in infected animals or the
simultaneous occurrence with other infections [4]. In
fact, the importance of some of these pathogens as a
cause of disease has not been clearly determined [5].
The genus Hepatozoon comprises more than 340 spe-
cies of apicomplexan protozoans of the family Hepato-
zoidae, are closely related to piroplasms and
haemosporids and infect a wide variety of amphibians,
reptiles, birds, and mammals [6]. The main transmission
route is through the ingestion of the definitive host, a
hematophagous arthropod, by the intermediate verte-
brate host [6]. Hepatozoon infection is well recognized
in dogs, in which two species are described, Hepatozoon
canis and Hepatozoon americanum [7]. However, in cats
infection is poorly understood [8]. Hepatozoonosis of
the domestic cat has been reported from different coun-
tries, including Brazil [9, 10], France [11], India [12],
Israel [8, 13], Nigeria [14], Portugal [4, 15], South-Africa
[16], Spain [17–19] and the USA [20]. Feline hepatozoo-
nosis is associated with infection of muscle tissues. It
has been generally considered that the infection is
mostly subclinical, although pathogenic effects may be
exacerbated in stressed, immunocompromised animals
or in concomitant infections [8].
On the contrary, infection in domestic cats with
Cytauxzoon felis is described as a cause of a progressive
usually fatal disease. Cytauxzoon spp. are apicomplexan
haemoparasites belonging to family Theileriidae trans-
mitted by ticks which infect wild and domestic felids
[21]. Several Cytauxzoon spp. have been identified with
C. felis being the most important. Historically, infection
with Cytauxzoon spp. in domestic cats was only reported
in North and South America, but it has been more
recently described in felids from Europe [22–26].
Limited previous molecular surveys have described
infection with Hepatozoon spp. [18, 19, 22, 26] and
Cytauxzoon spp. [22] in domestic cats from Spain.
Therefore, the main objectives of the current study were
to identify the presence and determine the prevalence of
vector-borne agents of the genera Hepatozoon and
Cytauxzoon in client-owned and stray cats from Madrid,
central Spain; and, due to the scarce information
available on the epidemiology and clinical manifestations
of feline hepatozoonosis and cytauxzoonosis in European
countries, to identify risk factors and clinical signs asso-
ciated with these infections in cats.
Methods
Animals and samples and data collection
Samples were collected from 644 cats between September
2005 and December 2008. The cats attended the Veterinary
Teaching Hospital (VTH) of the Complutense University
of Madrid, three different private veterinary clinics, or five
animal protection societies in the Madrid area. These
animals were mostly enrolled in a previous study that
assessed exposure and infection with Ehrlichia spp.,
Anaplasma spp., Neorickettsia spp., Leishmania spp., and
Bartonella spp., in client-owned and stray cats [5].
Written consent for patient enrolment was obtained
for every cat from owners or animal protection societies.
No specific inclusion or exclusion criteria were estab-
lished; therefore, any cat that attended the VTH or pri-
vate clinics from which blood samples were collected for
routine laboratory testing was enrolled in the study.
Stray cats at the animal protection societies were ran-
domly selected from those that were neutered/spayed.
Whenever available, different epidemiological and clin-
ical data were obtained from each cat. Feline Leukemia
virus (FeLV) and Feline Immunodeficiency virus (FIV)
status were determined by the use of a commercial kit
(IDEXX Laboratories, Westbrook, Maine, USA). Cats
were classified as healthy or unhealthy depending on the
clinical history and presence of clinical signs (general
signs, digestive signs, cardiovascular/respiratory signs,
ocular signs, musculoskeletal abnormalities, renal signs,
and neurological signs). In some cases, especially in cats
from shelters, the collected data were scarce and conse-
quently in some variables the sample size does not
include all the 644 studied cases. Nonetheless, all the
available data have been included due to the lack of
studies regarding this population and with the aim of
evaluating cats from different sources.
PCR amplification and sequencing
As described by Ayllón et al. [5], DNA was extracted
from 200 μl whole blood samples using an Ultra-
CleanTM DNA Blood Spin Kit (Mo Bio Laboratories,
Carlsbad, USA) following the manufacturer’s instruc-
tions. All DNA samples used for PCR were stored at
-80 °C until use. DNA was then quantified by spectro-
photometry and assessed for quality at 260/280 nm and
260/230 nm by spectrophotometry (NanoDropTM;
Thermo Scientific, Waltham, USA).
Subsequently, two previously described PCR protocols
based on piroplasmid 18S rRNA gene were performed
on the 644 samples for detection of Hepatozoon spp.
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and Cytauxzoon spp. DNA [19, 27] with some modifica-
tions. Table 1 shows the primers and protocols employed
in the PCR assays. Both PCR reactions were carried out
in a 25.5 μl reaction mixture containing 5 μl of genomic
DNA, 12.5 μl Premix Ex Taq™ (Lab. Conda, Madrid,
Spain) and 0.25 μl of each corresponding primer
(50 μM). Negative and positive controls were included
with each run.
The reactions were performed in an automatic DNA
thermal cycler MasterCycler® ep Gradient (Eppendorf,
Hamburg, Germany). The products of amplification
reactions were visualized by electrophoresis on 1.5%
agarose gel (PCR-1) and 1% (PCR-2) containing eth-
idium bromide (10 mg/ml) run at 115 V for 30 min for
the first PCR and 90 V for 30 min for the second PCR.
Negative samples were submitted to the housekeeping
gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
amplification to assess the extraction quality (DNA pres-
ence and absence of inhibition factors) in a single PCR
round as described by Birkenheuer et al. [28]. Primers and
protocol employed in this PCR assay are shown in Table 1.
The reaction products were purified using SpeedTools
PCR Clean-Up kit (Biotools, Madrid, Spain). Purified ampli-
fied DNA fragments from the positive samples were sub-
jected to sequencing in an automated sequencer 3730 DNA
Analyzer by using the Big Dye Terminator version 3.1(Ap-
plied Biosystems) by Secugen S.L (Madrid, Spain). Compar-
isons with sequences deposited in GenBank were made
using the Basic Local Alignment Search Tool (BLAST).
Statistical analysis
Statistical analysis of the results was performed by the
“Departamento de Ayuda a la Investigación, Área de
Informática y Comunicaciones” of the Complutense
University of Madrid, using the commercially available
statistical software SAS, version 9.4 (SAS Institute, Cary,
NC, USA). Statistical associations between PCR results
and haematological, biochemical and epidemiological
data were obtained from each cat and analysed by Chi-
square test or Fisher’s exact test and odds ratio (OR).
The significance level was set at P < 0.05.
Results
Cat description
Among the 644 cats included in this study, 506 (78.6%)
were client-owned and 138 (21.4%) were stray cats. Data
collected regarding epidemiological information are
shown in Tables 2 and 3. It was not possible to obtain
these data from all the animals included in the study,
particularly in the case of stray cats.
Clinical signs of disease and/or laboratory abnormal-
ities were found in 380 out of 542 (70.1%) cats for which
these data were available. General clinical signs were re-
corded in 33% (179/542); 31.2% (169/542) had gastro-
intestinal signs; 23.3% (126/542) had cardiovascular/
respiratory signs; 22.7% (123/542) had renal signs; 9.6%
(52/542) had ocular signs; 7.6% (41/542) had musculo-
skeletal abnormalities; and 3.2% (17/525) had neuro-
logical signs.
PCR amplification and sequencing
Of the 644 sampled cats, Hepatozoon spp. DNA was
amplified from 10 animals (1.6%). Sequencing con-
firmed H. felis infection in 9 cats (99–100% identity
to GenBank KC138534.1 in 8 cats and 100% to
HQ020489.1 and 99% to KC138534.1 in 1 cat). Hepa-
tozoon canis infection was confirmed in another cat,
with 99% identity to different close GenBank se-
quences, including isolates from ticks from Palestine
(KT587790.1) and Pakistan (JX441117.1), from dogs
from Israel (KC138535.1), India (JN584477.1) and Spain
(AY461378.2), from wild canids from Israel (KJ868815.1),
India (HQ829447.1) and Spain (AY731062.1) and from cats
from Israel (KC138532.2 and KC138531.2).
Cytauxzoon sp. DNA was amplified in 8 of the cat
samples (1.2%). The sequenced products showed 99–
100% identity with 18S rRNA gene of Cytauxzoon sp.
cat/France 1/2008 (EU622908.1), Cytauxzoon sp. wild
cat isolate 03/04326 (KT223486.1) and Cytauxzoon
manul (KU710344.1). No coinfection of Hepatozoon spp.
and Cytauxzoon sp. was detected in the cat population
of the study.
Table 1 Primers and protocols used for the amplification of Cytauxzoon sp., Hepatozoon spp. and housekeeping GAPDH gene
control
PCR primers (5′-3′) PCR conditions Product size (bp)
PCR-1 F: CCAGCAGCCGCGGTAATTC 94 °C, 3 min; 35 cycles [94 °C, 30 s, 64 °C, 45 s, 72 °C, 30 s];
72 °C, 7 min
373
R: CTTTCGCAGTAGTTYGTCTTTAACAAATCT
PCR-2 F: CCTGGTTGATCCTGCCAG 96 °C, 3 min; 40 cycles [96 °C, 1 min, 65 °C, 1 min, 72 °C,





F: CCTTCATTGACCTCAACTACAT 95 °C, 1 min; 45 cycles [94 °C, 4 s, 57 °C, 4 s, 72 °C, 3 s]; 72 °C, 1 min 282
R: CCAAAGTTGTCATGGATGACC
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Evaluation of epidemiological and clinical data
Results for the evaluation of associations between
positivity by PCR to Hepatozoon spp. and Cytaux-
zoon sp. and the epidemiological and clinical data
collected for the cat population of this study are
shown in Tables 2 and 3. When analyzing these
epidemiological data, age, gender, being spayed/neu-
tered and the breed of the cat did not show any sta-
tistically significant association with these infections.
Cytauxzoon sp. infection was detected mostly (6/8) in
blood samples drawn during winter months and infec-
tion was associated with the winter in comparison with
the other seasons together (P = 0.0091, OR = 7.54, 95%
CI: 1.50–37.71). The other two positive cats for this
agent included in the study were sampled during spring
and autumn. The season when the cats were included in
the study did not have a statistically significant influence
on Hepatozoon spp. prevalence (P = 0.2774), although
five and four out of the 10 positive samples were drawn
in winter and spring, respectively. Cats living in rural
areas had a higher prevalence of Cytauxzoon sp. infec-
tion (2.7%, 2/73) compared to cats living in periurban
(0.9%, 1/116) or urban (0/248) areas (P = 0.0463).
There was no statistically significant association
between positivity by PCR to Hepatozoon spp. or Cytaux-
zoon sp. and being a client-owned or a stray cat (P =
0.1492 and P = 0.0.691, respectively) or having outdoor
Table 2 Comparison of prevalence of Hepatozoon spp. and
Cytauxzoon sp. in association with different epidemiological data
Total no.
of cats (%)
No. of positive cats (%)
Hepatozoon spp. Cytauxzoon sp.




Spring 201 (31.2) 4 (2.0) 1 (0.5)
Summer 88 (13.7) 0 0
Autumn 168 (26.1) 1 (0.6) 1 (0.6)
Winter 187 (29.0) 5 (2.7) 6 (3.2)*
Age 547
Kitten (< 1 year-old) 107 (19.6) 2 (1.9) 1 (0.9)
Adult (1–10 year-old) 315 (57.6) 2 (0.6) 3 (1.0)
Older cat (> 10 year-
old)
125 (22.8) 0 0
Gender 589
Male 277 (47.0) 2 (0.7) 2 (0.7)
Female 312 (53.0) 3 (1.0) 2 (0.6)
Spayed/Neutered 548
Yes 311 (56.7) 3 (1.0) 1 (0.3)
No 237 (43.3) 2 (0.8) 3 (1.3)
Breed 585
European shorthair 439 (75.0) 4 (0.9) 3 (0.7)
Non-European
shorthair
146 (25.0) 1 (0.7) 1 (0.7)
Living area 440
Urban 248 (56.4) 3 (1.2) 0
Periurban 117 (26.6) 1 (0.9) 1 (0.9)
Rural 75 (17.0) 0 2 (2.7)*
Lifestyle 644
Client-owned 506 (78.6) 6 (1.2) 4 (0.8)
Stray 138 (21.4) 4 (2.9) 4 (2.9)
Outdoor access 506
Yes 269 (53.2) 4 (1.5) 6 (2.2)




Yes 392 (76.3) 8 (2.0) 7 (1.8)
No 122 (23.7) 0 0
Prey on wild animals 415
Yes 157 (37.8) 1 (0.6) 2 (1.3)
No 258 (62.2) 3 (1.2) 1 (0.4)
Previous tick infestation 413
Yes 30 (7.3) 1 (3.3) 0
No 383 (97.7) 3 (0.8) 3 (0.8)
Previous flea infestation 415
Yes 64 (15.4) 0 0
Table 2 Comparison of prevalence of Hepatozoon spp. and
Cytauxzoon sp. in association with different epidemiological data
(Continued)
No 351 (84.6) 4 (1.1) 3 (0.9)
Travel history 372
Yes 141 (38.0) 0 1 (0.7)
No 231 (62.0) 3 (1.3) 2 (0.9)
Ectoparasiticide treatment 488
Yes 103 (21.1) 2 (1.9) 1 (1.0)
No 385 (78.9) 5 (1.3) 6 (1.6)
Previous blood transfusion 389
Yes 5 (1.3) 1 (20.0)* 0
No 384 (98.7) 2 (0.5) 3 (0.8)
Tetracyclines treatment 391
Yes 13 (3.3) 2 (15.4)* 0
No 378 (96.7) 1 (0.3) 3 (0.8)
FeLV 482
Yes 35 (7.3) 2 (5.7) 0
No 447 (92.7) 5 (1.1) 7 (1.6)
FIV 484
Yes 26 (5.4) 0 2 (7.7)*
No 458 (94.6) 7 (1.5) 5 (1.1)
*P < 0.05 (statistically significant differences)
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access (P = 0.6894 and P = 0.1277, respectively). However,
when positive results to Hepatozoon spp. and to Cytaux-
zoon sp. were considered as a whole, stray cats were more
likely to be PCR positive (P = 0.0348), with a higher preva-
lence (5.8%, 8/138) than client-owned cats (2%, 10/506).
Previous history of tick or flea infestation, prey on wild
animals, lack of ectoparasiticide treatment and travel
history were not associated with positivity for these
pathogens. However, previous treatment with tetracy-
clines in the last 60 days and previous administration of
blood transfusion were associated with Hepatozoon spp.
infection (P = 0.0030, OR = 68.54, 95% CI: 5.77–813.77;
and P = 0.0382, OR = 47.75, 95% CI: 3.56–639.51,
respectively), but not with Cytauxzoon sp. infection.
When assessing FeLV/FIV status of the cats positive for
Hepatozoon spp. or Cytauxzoon sp. infections, although in
a non-significant manner (P = 0.0854, OR = 5.35, 95% CI:
1.00–28.67), a higher trend was found of Hepatozoon spp.
infection in cats positive for FeLV (5.7%, 2/35) in compari-
son with the cats negative for FeLV (1.1%, 5/447). All the
cats with amplification of Hepatozoon spp. DNA were
FIV-negative. On the contrary, none of the cats with amp-
lification of Cytauxzoon sp. DNA was positive for FeLV,
but two of them were positive for FIV (7.7%, 2/24), while
the prevalence of Cytauxzoon sp. infection in FIV-negative
cats was 1.1% (5/453). Consequently, FIV infection was
found statistically associated with Cytauxzoon sp. infection
(P = 0.0494, OR = 7.55, 95% CI: 1.39–40.93).
There was no statistically significant association
between the pathogens studied and the presence or
absence of any clinical signs. However, Hepatozoon spp.
infection was associated with a decrease in haematocrit
(P = 0.0375) and an increase in creatinine (P = 0.047).
Based on immunofluorescent antibody (IFA) tests, some
of the cats with Hepatozoon spp. or Cytauxzoon sp. infec-
tion had been exposed to other vector-borne pathogens.
Specifically, one cat with Hepatozoon spp. infection and
another with Cytauxzoon sp. infection were seropositive
for Ehrlichia canis. In addition, four of the Hepatozoon
spp.-infected cats and other four Cytauxzoon sp.-infected
cats were serologically positive for Bartonella henselae. It
was possible to confirm this concurrent infection with
Bartonella spp. by PCR from blood samples in one
Cytauxzoon sp.-positive stray cat, resulting in a
statistically significant association between these infections
(P = 0.0247).
Discussion
The detection of Hepatozoon felis, H. canis and Cytaux-
zoon sp. in blood samples from client-owned and stray
cats from Madrid reported in the present study suggests
that the feline population of this region is infected with
these apicomplexans, although with a low prevalence.
The diagnosis of Hepatozoon spp. in cats from central
Spain reported herein support that these protozoans
are widespread in the Iberian Peninsula, taking into ac-
count the previous descriptions in cat populations from
Table 3 Clinical parameters and relevant alterations in
laboratory findings of the cats studied
Total no. of
cats (%)
No. of positive cats (%)
Hepatozoon spp. Cytauxzoon sp.
644 10 (1.6) 8 (1.2)
Clinical signs 542
Yes 380 (70.1) 3 (0.8) 3 (0.8)
No 162 (29.9) 2 (1.2) 1 (0.6)
Haematology
Haematocrit 463
High 28 (6.0) 1 (3.6) 0
Low 87 (18.8) 3 (3.5) 1 (1.2)
Normal 348 (75.2) 2 (0.5)* 3 (0.9)
Leukocytes 460
High 88 (19.1) 2 (2.3) 1 (1.1)
Low 63 (13.7) 1 (1.6) 0
Normal 309 (67.2) 3 (1.0) 3 (1.0)
Platelets 168
High 14 (8.3) 0 0
Low 89 (53) 0 1 (1.1)
Normal 65 (38.7) 3 (4.6) 0
Biochemistry
Glucose 378
High 138 (36.5) 0 1 (0.7)
Low 3 (0.8) 0 0
Normal 237 (62.7) 3 (1.3) 3 (1.3)
Urea 419
High 101 (24.1) 1 (1.0) 0
Low 74 (17.7) 1 (1.4) 0
Normal 244 (58.2) 2 (0.8) 4 (1.6)
Creatinine 859
High 82 (18.6) 3 (3.7)* 0
Low 16 (3.6) 0 0
Normal 342 (77.7) 2 (0.6) 4 (1.2)
Total protein 408
High 135 (33.1) 1 (0.7) 1 (0.7)
Low 35 (8.6) 1 (2.9) 0
Normal 238 (58.3) 2 (0.8) 3 (1.3)
Alanine transaminase 441
High 76 (17.2) 2 (2.6) 2 (2.6)
Normal 365 (82.8) 3 (0.8) 1 (0.3)
*P < 0.05 (statistically significant differences)
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Portugal and different regions of Spain [4, 15, 17–19].
The sequencing of the PCR products amplified from
the cat samples in this study showed that both H. felis
and H. canis can infect cats in Spain, although H. felis
is by far more common, with only one cat infected with
H. canis. A similar higher ratio of H. felis versus H.
canis infection in domestic cats was also found in a
study from Israel where only two cats out of 55 Hepato-
zoon-spp.-positive cats were detected with H. canis in-
fection and 53 cats out of a total of 153 tested were
positive for H. felis [13]. The Hepatozoon infection
prevalences described in previous Spanish studies var-
ied from 0.6% in one study [17], 4% in cats from the
Barcelona area [19] and 16% in a cat colony from Bar-
celona [18], compared to the prevalence in our study of
1.6%. These differences in prevalence rates can be due
to the vector distribution, characteristics of the cat
populations in each case or differences in the PCR
technique and type of sample employed. No cats were
positive for Hepatozoon silvestris, a newly described fe-
line Hepatozoon species found in the European wildcats
(Felis silvestris silvestris) in Bosnia-Herzegovina [29].
Hepatozoon spp. are transmitted by ingestion of the
final host containing mature oocysts by the intermedi-
ate host [6]. Although the vectors of feline hepatozoo-
nosis are still unknown, it is expected that H. felis
would be transmitted by an hematophagus arthropod,
as demonstrated for other Hepatozoon spp. transmited
by fleas, ticks, mites, lice, mosquitoes and sand flies
[30, 31]. Variations in the possible vector distribution
can explain, at least partially, the differences in Hepato-
zoon spp. infection rates described in studies performed
in different regions. In our study, no statistical associ-
ation was found between positivity to Hepatozoon spp.
and a previous history of tick or flea infestation.
Other transmission routes have been described for
some Hepatozoon spp., including intrauterine transmis-
sion and carnivorism [13, 32, 33]. It was possible to
collect information regarding prey on wild animals from
four out of the ten Hepatozoon spp.-positive cats in the
current study and only one of them was reported to
ingest rodents, birds and other wild animals. However,
the other three Hepatozoon spp.-positive animals were
stray cats whose hunting activity was unknown.
No association was found between the lifestyle of
the cats (client-owned or stray) and positivity to
Hepatozoon spp. However, a higher prevalence of
Hepatozoon spp. infection has been described in
cats from a colony in the Barcelona area (16%) [18]
and in cats with outdoor access in comparison with
strictly indoor cats [4, 13]. In our study, positivity
to Hepatozoon spp. was not statistically related to
the outdoor access, but this information was avail-
able only for six out of the ten cats positive for
Hepatozoon spp. infection and four of them had
outdoor access.
One interesting finding of the current study is the ab-
sence of older cats (more than ten year-old) among
Hepatozoon spp.-infected cats. In agreement, a previous
retrospective study found that four out of seven cats
with hepatozoonosis were two year-old or younger [8].
In a later study, transplacental transmission of H. felis
was suggested as a mode of transmission as H. felis
DNA was shown to be present in foetuses of H. felis-
positive queens [13]. However, Maia et al. [4] found that
the prevalence of Hepatozoon spp. was higher in cats
older than 60 months (5 years).
In addition, five of the Hepatozoon spp.-positive cats
included in the current study were sampled during the
winter months (January and February), four during
spring (April and May) and one in autumn (October).
Due to the probable vector-borne transmission of H.
felis, this finding could be related to changes in vector
activity in different seasons of the year. The finding of a
higher prevalence in winter is unexpected, as the abun-
dance of competent vectors could decrease during the
colder months of the year. However, Baneth et al. [8]
described the detection of feline hepatozoonosis in the
Tel-Aviv area mainly in winter, suggesting that it could
be due to the occurrence of the infection during these
months, following a long life-cycle of the protozoa in
which gamonts appear in the peripheral blood several
months after the infection takes place in the warmer
months, or due to a chronic infection, with no direct re-
lation to the time of initial infection.
Feline hepatozoonosis is poorly understood [8]. It is
generally considered that Hepatozoon spp. infection in
cats has a low virulence, being mostly subclinical [13,
18], but there is scant clinical information on the
disease. Hepatozoon felis usually infects the myocardial
and skeletal muscles, with no significant local inflamma-
tory response [13, 34]. In the present study, no associ-
ation was found between the presence or absence of
clinical signs and Hepatozoon spp. infection. However,
the presence of lower haematocrit values (< 24%) and
higher creatinine levels (>1.8 mg/dl) were statistically
associated with this infection. When analysing this
result, it should be taken into account that two of the
three cats with Hepatozoon spp. infection that have low
haematocrit and high alanine-amino transaminase (ALT)
value, were also FeLV positive, with one of them also
being seropositive for B. henselae. In addition, clinical
signs and/or haematological alterations found in the cats
of the study should be interpreted cautiously, due to
possible coinfections with other pathogens not tested in
the current study, such as haemotropic mycoplasmas.
The presence of coinfections with FeLV or FIV and other
vector-borne pathogens has been frequently described in
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feline hepatozoonosis [4, 8, 13, 15, 18, 19] and compli-
cate the interpretation of clinical and laboratory findings.
In this sense, it has been suggested that hepatozoonosis
may develop in association with immunosupression in-
duced by a concurrent disease that can lead to the in-
tensification of parasitemia [8]. In our study, a
statistically significant association was found between
Hepatozoon spp.-positivity and previous tetracycline
treatment or previous blood transfusion. When analys-
ing these results, it should be considered that the total
animals included in this study with history of treatment
with these drugs in the last 60 days (3.3%, 13/391) or
that received blood transfusion previously (1.3%, 5/389)
is low. Tetracycline drugs are frequently prescribed
when a suspicion of a vector-borne disease exists, how-
ever, it has not been described to be effective against
Hepatozoon spp. Furthermore, the Hepatozoon spp.-
positive cat that had received a blood transfusion was
also treated with doxycycline and was FeLV and B. hen-
selae-positive.
Cytauxzoon sp. infection has been detected in eight
cats included in the present study, which comprise 1.2%
of the total number of cats analysed (644). The genus
Cytauxzoon includes several species with C. felis being
the most common in cats [35]. Cytauxzoon felis causes a
generally highly fatal disease in domestic cats in the
USA, with wild felids such as the bobcats (Lynx rufus)
and pumas (Puma concolor) as the main reservoirs for
this pathogen [35]. However, other species of Cytaux-
zoon infecting wild or domestic felids outside America
have been described, including C. manul, molecularly
characterized from a Pallas’ cat (Otocolobus manul) from
Mongolia [36, 37], and genetically-close Cytauxzoon sp.,
reported in wild felids and domestic cats from Spain,
France, Portugal and Italy [11, 22, 23, 25, 27, 38–41]. In-
formation on the epidemiology and clinical manifesta-
tions of infection of domestic cats by other species
distinct from C. felis is still scarce.
The analysis of sequenced PCR products showed that
Cytauxzoon sp. detected in cats from Spain in the current
study are very close to the previous isolates “Cytauxzoon
sp. wild cat isolate 03/04326” (KT223486.1) from Spain
[38], “Cytauxzoon sp. cat/France 1/2008” (EU622908.1)
from France [11], and “C. manul” (KU710344.1) from
Portugal [25]. As previously suggested, these isolates may
belong to the same species, but further studies are needed
to clarify the relatedness of the Cytauxzoon spp. infecting
felids outside the USA [23].
The prevalence of Cytauxzoon sp. infection detected
by PCR reported herein (1.2%) is lower than the previ-
ously described in Trieste region (north-eastern Italy),
where 23% of domestic cats were found to be infected
by this agent [23]. As described for C. felis, wild felids
can serve as reservoirs for this infection in the domestic
cat. In Spain, Cytauxzoon sp. infects the Iberian lynx
(Lynx pardinus) and wildcats (F. s. silvestris) [27, 38–40].
Due to the extremely low population size of the Iberian
lynx, it has been suggested that most likely, the natural
reservoir for Cytauxzoon sp. in the Iberian Peninsula is
the more abundant wildcat [35]. Interestingly, recent
studies have shown infection by C. felis in healthy do-
mestic cats, supporting the idea that not only wild felids
are competent reservoirs for this Cytauxzoon [42]. Euro-
pean domestic cats, especially those who roam freely,
could be acting as reservoirs for the Cytauxzoon sp.
present in these areas [23, 35].
In our study, cats living in rural areas had a higher
prevalence for this infection, with no amplification of
Cytauxzoon spp. DNA from cats living in urban areas.
This finding could be related to a higher exposure to the
currently unknown potential tick vector. In agreement
with that, the majority of the cats with Cytauxzoon sp.
infection in the present study had outdoor access (75%,
6/8). Another Cytauxzoon sp.-positive cat had no out-
door access, while information about outdoor access was
unkown for the last cat positive for this agent. Similarly,
Carli et al. [23] described in an epidemiological study
carried out in colony and owned cats from Italy that
Cytauxzoon sp. infection was significantly associated
with being free-ranging when compared with owned cats
from the same city, suggesting a higher risk of this infec-
tion in cats exposed to potential tick vectors and to
wildlife reservoirs, with a poor nutritional and clinical
status and without preventative treatment against
ectoparasites.
Surprisingly, our study showed a higher prevalence of
Cytauxzoon sp. infection in samples collected during the
colder months of the year, with the majority of positive
cats (6/8) included in the study between January and
March. This finding could be related to a chronic infec-
tion, but the possibility of the infection taking place in
winter months cannot be ruled out. On the contrary,
cytauxzoonosis caused by C. felis in the USA has been
described to show a seasonal incidence from spring to
early autumn [43]. Further studies with a large number
of Cytauxzoon sp.-infected animals are needed to clarify
transmission routes and epidemiology aspects of this
agent in Europe.
We did not find any association between the presence
or absence of clinical signs and Cytauxzoon sp. infection
in the cats of the study. The occurrence of a fatal disease
in a cat from Portugal infected by Cytauxzoon sp. has re-
cently been described [25], but subclinical infection was
highly prevalent in another epidemiological study [23].
Cytauxzoon felis infection has been described to fre-
quently cause anemia in the domestic cat [21, 44, 45]
and Criado-Fornelio et al. [22] described the presence of
low haematocrit and haemoglobin values in a Spanish
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Cytauxzoon sp.-infected cat that also showed an in-
creased level of glucose, hepatic enzymes and serum al-
bumin. Only one of the Cytauxzoon sp.-infected cat in
our study that had haematological and biochemical re-
sults showed slight normocytic, normochromic anemia,
lymphopenia, thrombocytopenia and hyperproteinemia.
However, this cat was also seropositive for B. henselae
and FIV-positive. In this sense, another Cytauxzoon sp.-
positive cat in our study was FIV positive, with statisti-
cally significant association between both infections. No
previous relation has previously been described between
Cytauxzoon spp. and retroviral infections [23, 46].
Finally, it should be considered that our study showed
a higher risk for positivity to hemoprotozoans in stray
cats compared to client-owned cats. This warrants
further studies to evaluate the possible reservoir role of
free roaming cats for these and other vector-borne
pathogens.
Conclusions
In summary, our results indicate that cats from Madrid
are infected with Hepatozoon spp. and Cytauxzoon sp.,
although with a low prevalence. A decrease in haemato-
crit value and an increase in creatinine value were asso-
ciated with Hepatozoon spp. infection. Cytauxzoon sp.
infection was more frequent in samples collected during
winter months and in cats living in rural areas and was
associated with a FIV-positive status. Infection with
these agents did not show association with the clinical
status or lifestyle (client-owned/stray) of the cats in-
cluded in the study. Further studies are needed to clarify
epidemiological and clinical aspects of these infections
in Spain.
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